An attractive strategy to standardize the microbiota is the use of gnotobiotic mice, i.e., mice with known microbial colonization status, which can be generated by introducing well-characterized microbial communities into germ-free animals
In gnotobiotic mice, fiber-deprived gut microbiota targets host mucin glycans as an Energy source
Transplantation of feces from cytolysin-positive patients with alcoholic hepatitis exacerbates ethanol-induced liver disease in gnotobiotic mice
Phage therapy against cytolytic E. faecalis abolishes ethanol-induced liver disease in gnotobiotic mice
The development of gnotobiotic animal models has enabled the effects of individual microbial species or strains to be assayed.
Gnotobiotic mice are raised in germ-free environments. They have fewer CD8+ T cells in their mesenteric lymph nodes (mLNs). They also have lower Interferon Type II (IFN Type II) / Interferon Gamma (IFN-g) levels in the small intestine (SI), colon, and Mesenteric Lymph Nodes (MLNs) / Superior mesenteric lymph nodes. This is compared to conventional lab mice
see also:
Gut microbiota & Virus Infections